Cargando…
Allosteric Theory: Taking Therapeutic Advantage of the Malleable Nature of GPCRs
The description of the allosteric modification of receptors to affect changes in their function requires a model that considers the effects of the modulator on both agonist affinity and efficacy. A model is presented which describes changes in affinity in terms of the constant α (ratio of affinity i...
Autor principal: | Kenakin, Terry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656818/ https://www.ncbi.nlm.nih.gov/pubmed/19305797 http://dx.doi.org/10.2174/157015907781695973 |
Ejemplares similares
-
Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015) -
Allosteric Modulation of GPCRs of Class A by Cholesterol
por: Jakubík, Jan, et al.
Publicado: (2021) -
Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators
por: Haack, Karla K.V., et al.
Publicado: (2011) -
Allosteric coupling from G protein to the agonist binding pocket in GPCRs
por: DeVree, Brian T., et al.
Publicado: (2016) -
Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs
por: Hollingsworth, Scott A., et al.
Publicado: (2019)